Does the media prefer VYGR or ETON?

In the previous week, Voyager Therapeutics had 1 more articles in the media than Eton Pharmaceuticals. MarketBeat recorded 3 mentions for Voyager Therapeutics and 2 mentions for Eton Pharmaceuticals. Eton Pharmaceuticals' average media sentiment score of 0.94 beat Voyager Therapeutics' score of 0.71 indicating that Eton Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Voyager Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Eton Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CYRX or VYGR?

In the previous week, CryoPort had 5 more articles in the media than Voyager Therapeutics. MarketBeat recorded 8 mentions for CryoPort and 3 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.71 beat CryoPort's score of 0.14 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CryoPort 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Voyager Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer VYGR or REPL?

In the previous week, Voyager Therapeutics and Voyager Therapeutics both had 3 articles in the media. Voyager Therapeutics' average media sentiment score of 0.71 beat Replimune Group's score of 0.44 indicating that Voyager Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Voyager Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Replimune Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor ORIC or VYGR?

In the previous week, Oric Pharmaceuticals had 1 more articles in the media than Voyager Therapeutics. MarketBeat recorded 4 mentions for Oric Pharmaceuticals and 3 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.71 beat Oric Pharmaceuticals' score of 0.47 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oric Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Voyager Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor KURA or VYGR?

In the previous week, Kura Oncology had 7 more articles in the media than Voyager Therapeutics. MarketBeat recorded 10 mentions for Kura Oncology and 3 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.71 beat Kura Oncology's score of -0.01 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kura Oncology 0 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Voyager Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Voyager Therapeutics (VYGR) Competitors

$3.32 -0.11 (-3.21%)

Closing price 04:00 PM Eastern

Extended Trading

$3.35 +0.03 (+0.84%)

As of 07:55 PM Eastern

Compare

VYGR vs. ETON, CYRX, REPL, ORIC, and KURA

Should you buy Voyager Therapeutics stock or one of its competitors? MarketBeat compares Voyager Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Voyager Therapeutics include Eton Pharmaceuticals (ETON), CryoPort (CYRX), Replimune Group (REPL), Oric Pharmaceuticals (ORIC), and Kura Oncology (KURA). These companies are all part of the "pharmaceutical products" industry.

How does Voyager Therapeutics compare to Eton Pharmaceuticals?

Voyager Therapeutics (NASDAQ:VYGR) and Eton Pharmaceuticals (NASDAQ:ETON) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Eton Pharmaceuticals has higher revenue and earnings than Voyager Therapeutics. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyager Therapeutics	$40.37M	4.97	-$119.72M	-$1.97	N/A
Eton Pharmaceuticals	$79.95M	10.60	-$4.60M	-$0.07	N/A

In the previous week, Voyager Therapeutics had 1 more articles in the media than Eton Pharmaceuticals. MarketBeat recorded 3 mentions for Voyager Therapeutics and 2 mentions for Eton Pharmaceuticals. Eton Pharmaceuticals' average media sentiment score of 0.94 beat Voyager Therapeutics' score of 0.71 indicating that Eton Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Voyager Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Eton Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Voyager Therapeutics presently has a consensus price target of $16.50, suggesting a potential upside of 396.99%. Eton Pharmaceuticals has a consensus price target of $41.00, suggesting a potential upside of 32.47%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe Voyager Therapeutics is more favorable than Eton Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyager Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
Eton Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

48.0% of Voyager Therapeutics shares are held by institutional investors. Comparatively, 27.9% of Eton Pharmaceuticals shares are held by institutional investors. 12.7% of Voyager Therapeutics shares are held by insiders. Comparatively, 16.5% of Eton Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Eton Pharmaceuticals has a net margin of -1.70% compared to Voyager Therapeutics' net margin of -319.61%. Eton Pharmaceuticals' return on equity of -5.68% beat Voyager Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Voyager Therapeutics	-319.61%	-55.97%	-43.12%
Eton Pharmaceuticals	-1.70%	-5.68%	-1.49%

Voyager Therapeutics has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, Eton Pharmaceuticals has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

Summary

Eton Pharmaceuticals beats Voyager Therapeutics on 10 of the 17 factors compared between the two stocks.

How does Voyager Therapeutics compare to CryoPort?

CryoPort (NASDAQ:CYRX) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

CryoPort has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, Voyager Therapeutics has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

In the previous week, CryoPort had 5 more articles in the media than Voyager Therapeutics. MarketBeat recorded 8 mentions for CryoPort and 3 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.71 beat CryoPort's score of 0.14 indicating that Voyager Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CryoPort	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Voyager Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

92.9% of CryoPort shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 10.0% of CryoPort shares are held by insiders. Comparatively, 12.7% of Voyager Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

CryoPort currently has a consensus target price of $15.11, suggesting a potential upside of 2.31%. Voyager Therapeutics has a consensus target price of $16.50, suggesting a potential upside of 396.99%. Given Voyager Therapeutics' higher possible upside, analysts clearly believe Voyager Therapeutics is more favorable than CryoPort.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CryoPort	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.80
Voyager Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

CryoPort has higher revenue and earnings than Voyager Therapeutics. Voyager Therapeutics is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CryoPort	$176.18M	4.23	$78.30M	$1.35	10.94
Voyager Therapeutics	$40.37M	4.97	-$119.72M	-$1.97	N/A

CryoPort has a net margin of 41.57% compared to Voyager Therapeutics' net margin of -319.61%. CryoPort's return on equity of -7.92% beat Voyager Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CryoPort	41.57%	-7.92%	-4.79%
Voyager Therapeutics	-319.61%	-55.97%	-43.12%

Summary

CryoPort beats Voyager Therapeutics on 12 of the 17 factors compared between the two stocks.

How does Voyager Therapeutics compare to Replimune Group?

Voyager Therapeutics (NASDAQ:VYGR) and Replimune Group (NASDAQ:REPL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

Voyager Therapeutics has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, Replimune Group has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market.

Voyager Therapeutics has higher revenue and earnings than Replimune Group. Replimune Group is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyager Therapeutics	$40.37M	4.97	-$119.72M	-$1.97	N/A
Replimune Group	N/A	N/A	-$247.30M	-$3.44	N/A

Voyager Therapeutics currently has a consensus target price of $16.50, indicating a potential upside of 396.99%. Replimune Group has a consensus target price of $4.88, indicating a potential downside of 42.44%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Voyager Therapeutics is more favorable than Replimune Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyager Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
Replimune Group	3 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.70

Replimune Group has a net margin of 0.00% compared to Voyager Therapeutics' net margin of -319.61%. Voyager Therapeutics' return on equity of -55.97% beat Replimune Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Voyager Therapeutics	-319.61%	-55.97%	-43.12%
Replimune Group	N/A	-102.69%	-72.22%

In the previous week, Voyager Therapeutics and Voyager Therapeutics both had 3 articles in the media. Voyager Therapeutics' average media sentiment score of 0.71 beat Replimune Group's score of 0.44 indicating that Voyager Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Voyager Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Replimune Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

48.0% of Voyager Therapeutics shares are held by institutional investors. Comparatively, 92.5% of Replimune Group shares are held by institutional investors. 12.7% of Voyager Therapeutics shares are held by insiders. Comparatively, 5.2% of Replimune Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Voyager Therapeutics beats Replimune Group on 13 of the 15 factors compared between the two stocks.

How does Voyager Therapeutics compare to Oric Pharmaceuticals?

Oric Pharmaceuticals (NASDAQ:ORIC) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Oric Pharmaceuticals has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Voyager Therapeutics has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market.

Voyager Therapeutics has higher revenue and earnings than Oric Pharmaceuticals. Oric Pharmaceuticals is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oric Pharmaceuticals	N/A	N/A	-$129.47M	-$1.44	N/A
Voyager Therapeutics	$40.37M	4.97	-$119.72M	-$1.97	N/A

Oric Pharmaceuticals has a net margin of 0.00% compared to Voyager Therapeutics' net margin of -319.61%. Oric Pharmaceuticals' return on equity of -35.33% beat Voyager Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oric Pharmaceuticals	N/A	-35.33%	-33.31%
Voyager Therapeutics	-319.61%	-55.97%	-43.12%

In the previous week, Oric Pharmaceuticals had 1 more articles in the media than Voyager Therapeutics. MarketBeat recorded 4 mentions for Oric Pharmaceuticals and 3 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.71 beat Oric Pharmaceuticals' score of 0.47 indicating that Voyager Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oric Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Voyager Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

95.1% of Oric Pharmaceuticals shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 5.7% of Oric Pharmaceuticals shares are held by insiders. Comparatively, 12.7% of Voyager Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Oric Pharmaceuticals currently has a consensus target price of $19.36, suggesting a potential upside of 156.81%. Voyager Therapeutics has a consensus target price of $16.50, suggesting a potential upside of 396.99%. Given Voyager Therapeutics' higher probable upside, analysts plainly believe Voyager Therapeutics is more favorable than Oric Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oric Pharmaceuticals	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
Voyager Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

Summary

Voyager Therapeutics beats Oric Pharmaceuticals on 8 of the 15 factors compared between the two stocks.

How does Voyager Therapeutics compare to Kura Oncology?

Kura Oncology (NASDAQ:KURA) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Kura Oncology has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, Voyager Therapeutics has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

48.0% of Voyager Therapeutics shares are held by institutional investors. 7.6% of Kura Oncology shares are held by company insiders. Comparatively, 12.7% of Voyager Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Voyager Therapeutics has lower revenue, but higher earnings than Kura Oncology. Kura Oncology is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kura Oncology	$67.48M	11.42	-$278.67M	-$3.35	N/A
Voyager Therapeutics	$40.37M	4.97	-$119.72M	-$1.97	N/A

Voyager Therapeutics has a net margin of -319.61% compared to Kura Oncology's net margin of -411.19%. Voyager Therapeutics' return on equity of -55.97% beat Kura Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kura Oncology	-411.19%	-141.95%	-43.28%
Voyager Therapeutics	-319.61%	-55.97%	-43.12%

Kura Oncology presently has a consensus price target of $25.58, suggesting a potential upside of 194.74%. Voyager Therapeutics has a consensus price target of $16.50, suggesting a potential upside of 396.99%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Voyager Therapeutics is more favorable than Kura Oncology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kura Oncology	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Voyager Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Kura Oncology had 7 more articles in the media than Voyager Therapeutics. MarketBeat recorded 10 mentions for Kura Oncology and 3 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.71 beat Kura Oncology's score of -0.01 indicating that Voyager Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kura Oncology	0 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Voyager Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Voyager Therapeutics beats Kura Oncology on 13 of the 17 factors compared between the two stocks.

Get Voyager Therapeutics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VYGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VYGR vs. The Competition

Export

Metric	Voyager Therapeutics	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$207.24M	$3.34B	$6.50B	$11.95B
Dividend Yield	N/A	2.31%	2.67%	5.61%
P/E Ratio	-1.69	10.45	20.85	21.87
Price / Sales	4.97	290.84	500.87	105.21
Price / Cash	N/A	120.20	43.05	54.72
Price / Book	0.94	8.00	10.43	6.70
Net Income	-$119.72M	$23.89M	$3.56B	$337.26M
7 Day Performance	-7.78%	-3.49%	-1.39%	-1.41%
1 Month Performance	-18.02%	1.03%	0.86%	1.15%
1 Year Performance	-4.05%	34.39%	19.42%	22.61%

Voyager Therapeutics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VYGR Voyager Therapeutics	3.4669 of 5 stars	$3.32 -3.2%	$16.50 +397.0%	+2.4%	$207.24M	$40.37M	N/A	100	News Coverage
ETON Eton Pharmaceuticals	4.5596 of 5 stars	$29.95 +2.8%	$41.00 +36.9%	+92.6%	$797.94M	$79.95M	N/A	20
CYRX CryoPort	2.5726 of 5 stars	$15.48 -1.4%	$15.11 -2.4%	+118.2%	$791.32M	$176.18M	11.47	1,186	News Coverage Analyst Forecast Insider Trade
REPL Replimune Group	1.3009 of 5 stars	$8.97 -5.3%	$4.88 -45.7%	-9.2%	$781.96M	N/A	N/A	210	Upcoming Earnings Gap Down
ORIC Oric Pharmaceuticals	2.5726 of 5 stars	$7.53 +0.4%	$19.36 +157.2%	-18.9%	$776.38M	N/A	N/A	80	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VYGR) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Voyager Therapeutics (VYGR) Competitors

VYGR vs. ETON, CYRX, REPL, ORIC, and KURA

How does Voyager Therapeutics compare to Eton Pharmaceuticals?

Summary

How does Voyager Therapeutics compare to CryoPort?

Summary

How does Voyager Therapeutics compare to Replimune Group?

Summary

How does Voyager Therapeutics compare to Oric Pharmaceuticals?

Summary

How does Voyager Therapeutics compare to Kura Oncology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VYGR vs. The Competition

Voyager Therapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Voyager Therapeutics (VYGR) Competitors

VYGR vs. ETON, CYRX, REPL, ORIC, and KURA

How does Voyager Therapeutics compare to Eton Pharmaceuticals?

Which has preferable earnings & valuation, VYGR or ETON?

Does the media prefer VYGR or ETON?

Do analysts prefer VYGR or ETON?

Do insiders & institutionals believe in VYGR or ETON?

Is VYGR or ETON more profitable?

Which has more volatility and risk, VYGR or ETON?

Summary

How does Voyager Therapeutics compare to CryoPort?

Which has more volatility and risk, CYRX or VYGR?

Does the media favor CYRX or VYGR?

Do insiders and institutionals have more ownership in CYRX or VYGR?

Do analysts recommend CYRX or VYGR?

Which has better earnings and valuation, CYRX or VYGR?

Is CYRX or VYGR more profitable?

Summary

How does Voyager Therapeutics compare to Replimune Group?

Which has more volatility & risk, VYGR or REPL?

Which has better earnings and valuation, VYGR or REPL?

Do analysts recommend VYGR or REPL?

Is VYGR or REPL more profitable?

Does the media prefer VYGR or REPL?

Do insiders & institutionals have more ownership in VYGR or REPL?

Summary

How does Voyager Therapeutics compare to Oric Pharmaceuticals?

Which has more risk and volatility, ORIC or VYGR?

Which has stronger earnings & valuation, ORIC or VYGR?

Is ORIC or VYGR more profitable?

Does the media favor ORIC or VYGR?

Do institutionals and insiders hold more shares of ORIC or VYGR?

Do analysts prefer ORIC or VYGR?

Summary

How does Voyager Therapeutics compare to Kura Oncology?

Which has more volatility and risk, KURA or VYGR?

Do insiders and institutionals hold more shares of KURA or VYGR?

Which has better valuation & earnings, KURA or VYGR?

Is KURA or VYGR more profitable?

Do analysts prefer KURA or VYGR?

Does the media favor KURA or VYGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VYGR vs. The Competition

Voyager Therapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools